Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

About Fellowship with AAHMS






Distinguished Laureate Professor
The University of Newcastle

Professor Nick Talley was appointed Pro Vice-Chancellor (and Dean) of the Faculty of Health and Medicine at the University of Newcastle, Australia, in 2010. He was formerly Chair of the Department of Internal Medicine at Mayo Clinic Jacksonville, Florida where he held the rank of Professor of Medicine and Professor of Epidemiology. He currently holds adjunct appointments as Professor at Mayo Clinic, the University of North Carolina and the Karolinska Institute. He is the current President of the Royal Australasian College of Physicians. Previously, Professor Talley was Foundation Professor of Medicine at the University of Sydney, Nepean Hospital.

Professor Talley is a neurogastroenterologist. With a current H-index of 111 (Scopus), he is listed among the worlds 400 most influential living biomedical researchers. His research is primarily focused on functional, neuromuscular and inflammatory disorders, including eosinophilic gut disorders, functional dyspepsia, Helicobacter pylori and reflux disease.

Professor Talley is currently co-editor-in-chief of the major international journal Alimentary Pharmacology & Therapeutics. Previously, he was co-editor-in-chief of the American Journal of Gastroenterology. He was a founding Director of the Rome Foundation and a past President of the Functional Brain-Gut Research Group (FBGRG). He has been a member of Medical Deans and holds a clinical appointment as Senior Staff Specialist at the John Hunter Hospital.

Awards received include the mentorship award from the Department of Medicine at Mayo Clinic in 2006 and the Distinguished Educator Award from the American Gastroenterological Association (AGA) in 2014, the Baker Presidential Lecture Award of the American College of Gastroenterology and the Masters of Clinical Research Award of the AGA in 2000, Research Scientist Award of the FBGRG in 2004, the Distinguished Research Award from the Gastroenterological Society of Australia in 2006, and the Rome Foundation Lifetime Award in 2011. He has entries in Who’s Who (Australia, USA) and Wikepedia.

Head, Department of Respiratory Medicine
Princess Margaret Hospital for Children

Professor Stick is Head, Department of Respiratory Medicine at Princess Margaret Hospital for Children, Research Strategy Leader at the Telethon Kids Institute and Clinical Professor, School of Paediatrics and Child Health, UWA. He has been a NHMRC Practitioner Fellow since 2000 and is acknowledged as a leader in early childhood lung diseases. His research interests span from cell and molecular biology to health service delivery with emphasis on translation of knowledge to improve health outcomes in children. He has supervised 12 successful PhD candidates and trained over 30 paediatric respiratory specialists, many of whom hold leadership positions around the world.

Former Dean, Faculty of Medicine Dentistry and Health Sciences
The University of Melbourne

Professor Stephen Smith led the creation of the United Kingdom’s first Academic Health Science Centre with the merger of two NHS Acute Trusts and Imperial College London, becoming the first CEO and Principal in 2007 of Imperial College Healthcare NHS Trust. These organisations are now an integral part of the NHS research structure that puts the UK at the forefront of translational and implementation research. His research with the MRC and the University of Cambridge was at the forefront of highlighting the role of angiogenesis in the non-pregnant and pregnant female reproductive tract in health and disease.

Deputy Director, Queensland Children’s Medical Research Institute
University of Queensland

Professor Peter Sly is an acknowledged pioneer in understanding the early origins of lung disease and the implications for lung health in the long term. He has discovered major risk factors for the development of asthma and for the onset of cystic fibrosis lung disease, leading to a number of testable hypotheses to prevent or delay the onset of lung disease, which are currently being trialled internationally. He has been instrumental in developing methods for measuring lung function in infants which enable for the first time the study of antenatal versus postnatal environmental influences on lung growth and development. Peter Sly is at the forefront of international thinking on the prevention of lung disease in children.

Associate Director & NHMRC Principal Research Fellow
Murdoch Childrens Research Institute

Professor Sinclair’s groundbreaking research, including the discovery of the Y-linked SRY (testis) gene, underpin our understanding of normal and dysfunctional gonad development and its impact on children with Disorders of Sex Development. Importantly, he has translated his work into the clinic by developing much-needed rapid and accurate diagnostic tests. His research excellence, along with his prominent role in research translation, exemplary service to medical genetics community and more broadly as President of the Australian Society for Medical Research and member of the NHMRC Human Genetics Advisory Committee makes Professor Sinclair an outstanding candidate for election to the Academy.

Deputy Director, Clinical and Population Health
Baker Heart and Diabetes Institute

Professor Jonathan Shaw is one of the world leaders in the epidemiology of diabetes. He has published over 250 peer-reviewed papers, has over 2,700 citations annually, and was one of only seven Australians listed in the Clinical Medicine section of the Thomson Reuters “The World’s Most Influential Scientific Minds 2014”. His work has ranged from discovering risk factors for diabetes to developing clinical guidelines and a diabetes risk screening tool. His frequent media appearances contribute to the public understanding of science, and he has taken a leading role in academic and clinical aspects of Indigenous health as it relates to diabetes.

Executive Director & CEO
Neuroscience Research Australia (NeuRA)

Professor Peter Schofield is Executive Director and CEO of NeuRA – Neuroscience Research Australia – one of Australia’s leading independent neuroscience research centres, and Professor of Medicine at UNSW. His research has fundamentally altered the understanding of neurotransmitter signaling and has identified the role of genes that lead to neurodegenerative and psychiatric disorders such as Alzheimer’s disease and bipolar disorder. He has published over 290 papers. He has taken leadership roles in professional organizations including ASMR, Research Australia, on government committees and in the development of NeuRA’s research program that addresses clinical and laboratory research addressing both neurological and psychiatric disorders.

Laureate Professor, Paediatric Neurology Research
The University of Melbourne & Florey Institute of Neuroscience and Mental Health

Professor Ingrid Scheffer is a physician-scientist whose work as a paediatric neurologist and epileptologist at the University of Melbourne and Florey Institute has led the field of epilepsy genetics over more than 20 years, in collaboration with Professor Samuel Berkovic and molecular geneticists. This resulted in identification of the first epilepsy gene and many more genes subsequently. Professor Scheffer has described many novel epilepsy syndromes and performed genotype-phenotype correlation. She recently played a key role in the first major reclassification of the epilepsies in two decades as Chair of the International League Against Epilepsy Commission for Classification and Terminology.

She obtained her medical degree from Monash University and her PhD from the University of Melbourne for which she received the Chancellor’s Award. She trained in paediatrics at the Royal Children’s Hospital in Melbourne, paediatric neurology at The Great Ormond Street Hospital for Sick Children, London UK, and epileptology at the Austin Hospital. In her PhD on the genetics of the epilepsies, she described four novel epilepsy syndromes which served as the basis for gene discovery.

She has received many awards: 2007 American Epilepsy Society Clinical Research Recognition Award, 2009 RACP Eric Susman Prize, 2013 GSK Award for Research Excellence, ILAE Ambassador for Epilepsy Award, 2013 Australian Neuroscience Medallion, 2013 Emil Becker Prize for child neurology and the L’Oreal-UNESCO Women in Science Laureate for the Asia-Pacific region for 2012. In 2014, she was elected as a Fellow of the Australian Academy of Sciences. She was awarded the Order of Australia in 2014 for “distinguished service to medicine in the field of paediatric neurology as a clinician, academic and mentor, and to research into the identification of epilepsy syndromes and genes”. Together with Professor Sam Berkovic, she was awarded the 2014 Prime Minister’s Prize for Science.

Head of Biomedical Imaging and Prostate Cancer Models
Australian Prostate Cancer Research Centre – Queensland, Queensland University of Technology

Highly creative scientist, Professor Pam Russell, initiated cyclophosphamide therapy for autoimmunity and is internationally recognized for generating urological cancer models for study. She directed the Oncology Research Centre, Prince of Wales Hospital, Sydney for 17 years, published 200 papers, patents, procured $34m in grants and mentored postgraduates and 30 postdoctoral fellows. Discoveries include antibodies to diagnose and image prostate cancer and innovative gene therapy. Regularly invited to collaborate, present worldwide, contribute book chapters, edit specialist journals, review and join global scientific committees, she founded the Prostate Cancer Foundation of Australia, interacting with public groups. Awards include Australian honours for research contributions.


Vale Pamela Russell, February 2022.

Professor of Surgery, Monash University; Senior Neurosurgeon, Alfred Hospital
Monash University

Professor Jeffrey Rosenfeld is an Australian and international leader in neurosurgery and military surgery. He has conducted seminal research in brain and spine injury, paediatric epilepsy, stem cell applications and bionic vision. He is Founding Director of the Monash Institute of Medical Engineering (MIME) and is a champion of interdisciplinary research. He is Professor of Surgery, Monash University; Director, Neurosurgery, Alfred Hospital; and has Adjunct Professorships in USA and PNG. He has had extensive engagement in developing countries and longstanding community involvement in Australia. His many appointments include Major General, the Australian Defence Force (ADF) and immediate past Surgeon General, ADFReserves.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.